BioMarin Pharmaceutical
BMRN
#1870
Rank
A$15.48 B
Marketcap
A$80.54
Share price
-3.04%
Change (1 day)
-19.97%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : A$2.18 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total liabilities are A$2.18 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioMarin Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$2.24 B5.15%
2024-12-31A$2.13 B-22.87%
2023-12-31A$2.77 B6.54%
2022-12-31A$2.60 B8.55%
2021-12-31A$2.39 B5.88%
2020-12-31A$2.26 B1.18%
2019-12-31A$2.23 B8.1%
2018-12-31A$2.07 B-11.37%
2017-12-31A$2.33 B33.97%
2016-12-31A$1.74 B-4.35%
2015-12-31A$1.82 B57.52%
2014-12-31A$1.15 B14.36%
2013-12-31A$1.01 B90.39%
2012-12-31A$0.53 B2.36%
2011-12-31A$0.51 B-3.24%
2010-12-31A$0.53 B-18.94%
2009-12-31A$0.66 B-25.83%
2008-12-31A$0.89 B24.41%
2007-12-31A$0.71 B63.71%
2006-12-31A$0.43 B17.62%
2005-12-31A$0.37 B-4.14%
2004-12-31A$0.38 B108.73%
2003-12-31A$0.18 B769.45%
2002-12-31A$21.42 M-10.82%
2001-12-31A$24.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sanofi
SNY
A$93.91 B 4,194.68%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
A$2.32 B 6.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.11 B-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.18 B-45.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.98 B-55.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$0.21 B-90.07%๐Ÿ‡บ๐Ÿ‡ธ USA